Trial Profile
A prospective, randomized study investigating efficacy of Alogliptin alone versus Alogliptin + Pioglitazone in insulin resistant and severely obese women with polycystic ovary syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2016
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jul 2016 New trial record